Viteava Pharmaceuticals Overview

  • Founded
  • 2013

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Viteava Pharmaceuticals General Information


Developer of anti-cancer compound isolated from green tea designed to improve the treatment and management of cancer and related conditions. The company's proprietary drug approach targets pathways that inhibit tumor cell proliferation, enabling patients to enhance the quality of life.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Toronto, Ontario
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viteava Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Apr-2018 Completed Out of Business
5. Seed Round Cancelled Startup
4. Accelerator/Incubator Completed Startup
3. Grant Completed Startup
2. Grant 01-Apr-2014 $27K Completed Startup
1. Accelerator/Incubator 28-Jan-2014 Completed Startup
To view Viteava Pharmaceuticals’s complete valuation and funding history, request access »